Millipore Sigma Vibrant Logo

219465 Celastrol, Celastrus scandens - CAS 34157-83-0 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
34157-83-0C₂₉H₃₈O₄

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
219465-10MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 10 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA cell-permeable dienone-phenolic triterpene compound that exhibits antioxidant and anti-inflammatory properties. It suppresses LPS-induced pro-inflammatory cytokines release in macrophages and monocytes (IC50 = 40 nM for IL-1β and IL-1α, 80 nM for IL-6, 110 nM for PGE2, and 210 nM for IL-8 and TNF-α), as well as LPS-induced NF-κB activation (IC50 = 270 nM) and NO production (IC50 = 230 nM) in RAW264.7 cells. Preferentially inhibits chymotrypsin-like activity of 20S proteasome with an IC50 of 2.5 µM. Has also been shown to inhibit lipid peroxidation induced by ADP and Fe2+ in rat liver mitochondria (IC50 = 7 µM). Significantly improves the performance in memory, learning, and psychomotor activity in rats. May be useful to minimize inflammation in Alzheimer′s disease (AD).
      Catalogue Number219465
      Brand Family Calbiochem®
      SynonymsTripterin, 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid, Proteasome Inhibitor XIX
      References
      ReferencesYang, H., et al. 2006. Cancer Res. 66, 4758.
      Westerheide, S.D., et al. 2004. J. Biol. Chem. 279, 56053.
      Jin, H.Z., et al. 2002. J. Nat. Prod. 65, 89.
      Allison, A.C., et al. 2001. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341.
      He, W., et al. 1998. Bioorg. Med. Chem. Lett. 8, 3659.
      Sassa, H., et al. 1990. Biochem. Biophys. Res. Commun. 172, 890.
      Product Information
      CAS number34157-83-0
      ATP CompetitiveN
      FormRed crystals
      Hill FormulaC₂₉H₃₈O₄
      Chemical formulaC₂₉H₃₈O₄
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Target20S proteasome
      Primary Target IC<sub>50</sub>2.5 µM inhibiting chymotrypsin-like activity of 20S proteasome
      Purity≥95% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      219465-10MG 04055977218459

      Documentation

      Celastrol, Celastrus scandens - CAS 34157-83-0 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Celastrol, Celastrus scandens - CAS 34157-83-0 - Calbiochem Analysenzertifikate

      TitelChargennummer
      219465

      Literatur

      Übersicht
      Yang, H., et al. 2006. Cancer Res. 66, 4758.
      Westerheide, S.D., et al. 2004. J. Biol. Chem. 279, 56053.
      Jin, H.Z., et al. 2002. J. Nat. Prod. 65, 89.
      Allison, A.C., et al. 2001. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341.
      He, W., et al. 1998. Bioorg. Med. Chem. Lett. 8, 3659.
      Sassa, H., et al. 1990. Biochem. Biophys. Res. Commun. 172, 890.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-June-2008 RFH
      SynonymsTripterin, 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid, Proteasome Inhibitor XIX
      DescriptionA cell-permeable dienone-phenolic triterpene compound with antioxidant and anti-inflammatory properties. It suppresses LPS-induced release of pro-inflammatory cytokines in macrophages and monocytes (IC50 = 40 nM for IL-1β and IL-1α, 80 nM for IL-6, 110 nM for PEG2, and 210 nM for IL-8 and TNF-α). Also suppresses LPS-induced NF-κB activation (IC50 = 270 nM) and NO production (IC50 = 230 nM) in RAW264.7 cells. Preferentially inhibits chymotrypsin-like activity of 20S proteasome with an IC50 of 2.5 µM. Shown to inhibit lipid peroxidation induced by ADP and Fe2+ in rat liver mitochondria (IC50 = 7 µM). Improves performance in memory, learning, and psychomotor activity in rats. May be useful in minimizing inflammation in Alzheimer's disease animal models.
      FormRed crystals
      Intert gas (Yes/No) Packaged under inert gas
      CAS number34157-83-0
      Chemical formulaC₂₉H₃₈O₄
      Structure formulaStructure formula
      Purity≥95% by TLC
      SolubilityDMSO (5 mg/ml) or Ethanol
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesYang, H., et al. 2006. Cancer Res. 66, 4758.
      Westerheide, S.D., et al. 2004. J. Biol. Chem. 279, 56053.
      Jin, H.Z., et al. 2002. J. Nat. Prod. 65, 89.
      Allison, A.C., et al. 2001. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341.
      He, W., et al. 1998. Bioorg. Med. Chem. Lett. 8, 3659.
      Sassa, H., et al. 1990. Biochem. Biophys. Res. Commun. 172, 890.